查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598480

毒理学测试外包市场：按方法、业务类型、最终用途划分 – 2025-2030 年全球预测

Toxicity Testing Outsourcing Market by Method (In-Vitro toxicity testing, In-Vivo toxicity testing), Practice Type (Good Laboratory Practices (GLP), Non-GLP), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年毒理学测试外包市场规模为39.7亿美元，预计2024年将达到43.1亿美元，复合年增长率为9.03%，预计到2030年将达到72.8亿美元。

毒理学测试外包的范围涉及与外部实验室和服务供应商签订合同，进行测试以评估化学品、药物和其他物质的安全性和潜在有害影响。由于公司需要遵守严格的监管要求、控製成本并利用内部不具备的专业知识，因此必须采用这种方法。最终用途包括製药、化妆品、食品和饮料以及製药、农业化学品、生物技术和消费品等行业的环境分析。市场成长的推动因素包括研发费用的增加、测试方法的技术进步以及对化学品安全和环境影响意识的增强。此外，向非动物测试的转变以及对毒性预测和高通量筛检的重视正在为创新和持续研究开闢新的途径。新兴市场的扩张和日益严格的法律规范也推动了对专业服务的需求。

主要市场统计
基准年[2023] 39.7亿美元
预测年份 [2024] 43.1亿美元
预测年份 [2030] 72.8亿美元
复合年增长率（%） 9.03%

然而，一些挑战阻碍了市场的扩张。其中包括监管障碍、对动物测试的道德担忧以及先进测试技术的高成本。此外，不同地区的不同法规可能会使全球企业发展变得复杂，并且需要测试能够适应不同司法管辖区并合规的解决方案。儘管存在这些挑战，投资于技术主导的创新，例如将人工智慧和机器学习整合到毒性预测模型中以及扩大伙伴关係和协作，可以推动市场成长。

公司应优先考虑并利用体外、电脑和替代测试方法、能源和成本效益高的流程以及生物技术在毒性预测中的应用的创新发展。市场是动态的，并随着技术进步和监管环境的变化而发展，突显出需要持续监控和适应，以跟上新趋势和法律变化。参与研究联盟进一步促进知识共用，加速整个网路产业标准的进步，并确保持续的业务成长。

市场动态：揭示快速发展的毒理学测试外包市场的关键市场洞察

毒理学测试外包市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 动物实验的伦理问题日益严重
    • 对药物发现和个人化医疗的日益关注
    • 增加毒性资料库
  • 市场限制因素
    • 缺乏确定体内条件复杂性的标准
  • 市场机会
    • 由于 3D 细胞培养系统的发展，毒性测试服务的接受范围扩大
    • 由于节省时间的安全参数，毒性测定被广泛采用
  • 市场挑战
    • 缺乏经过毒性测试程序训练的专家

波特五力：驾驭毒理学测试外包市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解毒理学测试外包市场的外部影响

外部宏观环境因素在塑造毒理学测试外包市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解毒理学测试外包市场的竞争格局

对毒理学测试外包市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵毒性测试外包市场供应商绩效评估

FPNV 定位矩阵是评估毒理学测试外包市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了毒理学测试外包市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，毒理学测试外包市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 动物实验的伦理问题日益严重
      • 对药物发现和个人化医疗的日益关注
      • 增加毒性资料库
    • 抑制因素
      • 缺乏建立体内复杂情况的标准
    • 机会
      • 3D 细胞培养系统的进步提高了毒性测试服务的接受度
      • 由于安全且省时的参数，毒性测试被广泛采用
    • 任务
      • 缺乏经过训练的毒性测试程序专业知识
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章毒理学测试外包市场：依方法

  • 试管内毒性试验
  • 体内毒性试验

第七章依治疗类型分類的毒理学测试外包市场

  • 良好实验室规范 (GLP)
  • 非GLP

第八章毒理学测试外包市场：依最终用途分类

  • 学术研究所
  • 製药和生物製药公司

第九章 北美、南美毒理学检测外包市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太毒理学检测外包市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲毒理学检测外包市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biognosys AG
  • BioIVT, LLC
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Eagle Analytical
  • Eurofins Scientific Limited
  • Evotec SE
  • Laboratory Corporation of America Holdings
  • Lonza Group Ltd.
  • Merck KGaA
  • Perkinelmer Inc.
  • Promega Corporation
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • SGS SA
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-1D39DE28BC82

The Toxicity Testing Outsourcing Market was valued at USD 3.97 billion in 2023, expected to reach USD 4.31 billion in 2024, and is projected to grow at a CAGR of 9.03%, to USD 7.28 billion by 2030.

The scope of toxicity testing outsourcing involves contracting external laboratories and service providers to conduct tests assessing the safety and potential harmful effects of chemicals, pharmaceuticals, and other substances. This approach is necessitated by the need for organizations to comply with stringent regulatory requirements, manage costs, and access specialized expertise not available in-house. It finds application across industries such as pharmaceuticals, agrochemicals, biotechnology, and consumer goods, with end-use sectors including pharmaceuticals, cosmetics, food and beverage, and environmental analysis. Market growth is driven by increasing R&D expenditures, technological advancements in testing methodologies, and heightened awareness of chemical safety and environmental impact. Additionally, the move towards animal-free testing and emphasis on predictive toxicity and high-throughput screening open fresh avenues for innovation and ongoing research. Opportunities also arise from expanding markets in emerging economies where regulatory frameworks are becoming more stringent, thereby fueling demand for expert services.

KEY MARKET STATISTICS
Base Year [2023] USD 3.97 billion
Estimated Year [2024] USD 4.31 billion
Forecast Year [2030] USD 7.28 billion
CAGR (%) 9.03%

However, several challenges impede market expansion. These include regulatory hindrances, ethical concerns regarding animal testing, and the high cost of advanced testing technologies. Moreover, varying regional regulations can create complexities for global operations, necessitating adaptable and compliant testing solutions across different jurisdictions. Despite these challenges, investing in technology-driven innovations, such as artificial intelligence and machine learning integration in toxicity prediction models and expanding partnerships and collaborations, can catalyze market growth.

Firms should prioritize innovative development in in vitro, in silico, and alternative testing methods, energy-efficient and cost-effective processes, and use of biotechnology in toxicity forecasting to edge ahead. The market is dynamic, evolving with technological progress and shifting regulatory landscapes, thus emphasizing the need for continuous monitoring and adaptation to identify emerging trends and legislative changes promptly. Engaging in research consortia can further facilitate knowledge sharing and drive industry-standard advancements across networks, ensuring sustained business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Toxicity Testing Outsourcing Market

The Toxicity Testing Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising ethical issues about animal testing
    • Increasing focus on drug discovery and personalized medicine
    • Growing number of toxicity databases
  • Market Restraints
    • Lack of standards to establish intricacies of in-vivo conditions
  • Market Opportunities
    • Growing acceptance of toxicity testing services with the evolution of 3D cell culture systems
    • Extensive adoption of toxicology assays attributed to safety time-saving parameters
  • Market Challenges
    • Lack of trained expertise for the toxicity testing procedure

Porter's Five Forces: A Strategic Tool for Navigating the Toxicity Testing Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Toxicity Testing Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Toxicity Testing Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Toxicity Testing Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Toxicity Testing Outsourcing Market

A detailed market share analysis in the Toxicity Testing Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Toxicity Testing Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Toxicity Testing Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Toxicity Testing Outsourcing Market

A strategic analysis of the Toxicity Testing Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Toxicity Testing Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biognosys AG, BioIVT, LLC, Catalent, Inc., Charles River Laboratories International, Inc., Danaher Corporation, Eagle Analytical, Eurofins Scientific Limited, Evotec SE, Laboratory Corporation of America Holdings, Lonza Group Ltd., Merck KGaA, Perkinelmer Inc., Promega Corporation, Qiagen N.V., Quest Diagnostics Incorporated, SGS S.A., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Toxicity Testing Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Method, market is studied across In-Vitro toxicity testing and In-Vivo toxicity testing.
  • Based on Practice Type, market is studied across Good Laboratory Practices (GLP) and Non-GLP.
  • Based on End-Use, market is studied across Academic & Research Institutes and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising ethical issues about animal testing
      • 5.1.1.2. Increasing focus on drug discovery and personalized medicine
      • 5.1.1.3. Growing number of toxicity databases
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of standards to establish intricacies of in-vivo conditions
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing acceptance of toxicity testing services with the evolution of 3D cell culture systems
      • 5.1.3.2. Extensive adoption of toxicology assays attributed to safety time-saving parameters
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of trained expertise for the toxicity testing procedure
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Toxicity Testing Outsourcing Market, by Method

  • 6.1. Introduction
  • 6.2. In-Vitro toxicity testing
  • 6.3. In-Vivo toxicity testing

7. Toxicity Testing Outsourcing Market, by Practice Type

  • 7.1. Introduction
  • 7.2. Good Laboratory Practices (GLP)
  • 7.3. Non-GLP

8. Toxicity Testing Outsourcing Market, by End-Use

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Pharmaceutical & Biopharmaceutical Companies

9. Americas Toxicity Testing Outsourcing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Toxicity Testing Outsourcing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Toxicity Testing Outsourcing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Biognosys AG
  • 5. BioIVT, LLC
  • 6. Catalent, Inc.
  • 7. Charles River Laboratories International, Inc.
  • 8. Danaher Corporation
  • 9. Eagle Analytical
  • 10. Eurofins Scientific Limited
  • 11. Evotec SE
  • 12. Laboratory Corporation of America Holdings
  • 13. Lonza Group Ltd.
  • 14. Merck KGaA
  • 15. Perkinelmer Inc.
  • 16. Promega Corporation
  • 17. Qiagen N.V.
  • 18. Quest Diagnostics Incorporated
  • 19. SGS S.A.
  • 20. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. TOXICITY TESTING OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. TOXICITY TESTING OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TOXICITY TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TOXICITY TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TOXICITY TESTING OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TOXICITY TESTING OUTSOURCING MARKET DYNAMICS
  • TABLE 7. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN-VITRO TOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN-VIVO TOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GOOD LABORATORY PRACTICES (GLP), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY NON-GLP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. TOXICITY TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. TOXICITY TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023